Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…ected. Forty-eight patients received B-cell targeted therapies (belimumab 40=; rituximab n=8). For these, treatment duration, reasons for…
…ge: 17W–187W). At W28, higher proportions of patients receiving ianalumab achieved SRI-4 (70.6%), SRI-6 (50.0%), LLDAS (17.6%), DORIS (11…
…h results from pivotal trials (TULIP-1 and TULIP-2), supporting anifrolumab as an effective therapeutic option for patients with SLE, altho…
…ct PO:11:285 Table 1Conclusions A small subset of patients with SLE achieve prolonged remission after a single rituximab course, wi…
…ubunit 1, blocks interferon-mediated signaling a key pathway in SLE immunopathogenesis.To describe real-world effectiveness, glucoc…
…hods Observational multicenter study of patients diagnosed with SLE (EULAR/ACR 2019 classification criteria) treated with ANI. Demo…
…CR 2019, SLICC and/or ACR 1997 diagnostic criteria treated with Belimumab in monotherapy. Data were collected from medical records of SLE…
… clinical responses to belimumab following rituximab therapy in SLE. These findings provide a feasible enrichment strategy that has…
…N) tapering versus maintenance of low-dose PDN on flare risk in SLE patients in remission.Methods Observational, retrospective coho…
… behaviours during early pregnancy and the risk and severity of gestational diabetes mellitus (GDM), with a particular focus on smoking status, smoking inten…
…0 deliveries and 31 born children. Among singleton pregnancies, gestational diabetes was present in seven (24%), gestational hypertension or pre-ecl…